Law: Inflation Reduction Act 2022 (USA)

How to navigate the biosimilar and biologic markets amid challenging US litigation trends

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

A slew of recent litigation in the biologics and biosimilars space has drastically changed the landscape of this space and made it more challenging for biopharma companies and IP professionals.

24 June 2024